AssetMark’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
AssetMark's TNDM Position: Q3 2026 in Review
AssetMark increased its Tandem Diabetes Care (TNDM) stake by 30% in Q3 2026, buying an estimated $9.8K and bringing the position to 2,271 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.
AssetMark first reported a position in TNDM in Q3 2024 and has held it in 9 quarters since. The position peaked at $44.1K in Q4 2024. 210 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.
- AssetMark held 2,271 shares of Tandem Diabetes Care worth $37K as of Q3 2026.
- AssetMark bought 521 Tandem Diabetes Care shares in Q3 2026, an estimated $9.8K.
- Tandem Diabetes Care made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1999 holding.
- AssetMark first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 9 quarters since.
- AssetMark's Tandem Diabetes Care position peaked at $44.1K in Q4 2024.
- 210 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.